Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin143%+3.4pp141.3%-0.9pp139.9%-6.1pp139.2%-10.0pp139.6%-12.0pp
Operating margin78.5%-0.6pp77.3%-4.7pp78%-7.2pp78.3%-9.0pp79.1%-10.6pp
Net margin65.7%-3.1pp65%-7.1pp65.9%-9.2pp67%-9.9pp68.8%-8.0pp
Returns
Return on equity70.6%-2.0pp68.9%-7.1pp69.8%-9.9pp70.6%-12.2pp72.6%-10.6pp
Return on invested capital72.5%-4.6pp71.1%-11.5pp72.4%-16.0pp74.2%-19.4pp77.1%-20.7pp
Efficiency
Asset turnover3.2×0.0×3.2×0.0×3.1×0.0×3.1×-0.1×3.2×-0.1×
Liquidity
Current ratio11.4×+0.5×11.4×+0.7×11.2×+0.4×11.3×-0.2×10.9×-1.9×
Leverage
Debt-to-equity0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.5×0.0×
Net debt / EBITDA-1.6×-0.7×-1.5×-0.4×-1.1×+0.4×-0.9×+1.1×-0.8×+1.6×
Per Share
Book value per share$167.42+15.0%$162.87+12.4%$155.58+6.0%$151.05+2.5%$145.61-2.2%
Valuation
Market capitalization$72.72B-15.5%$70.84B-28.4%$74.77B-26.2%$77.82B-27.5%$86.03B-22.8%
Price / earnings144.6×-28.2×145.9×-43.4×154×-31.1×159.5×-31.6×172.8×-27.0×
Price / sales23.7×-6.1×23.7×-10.5×25.4×-9.4×26.8×-9.9×29.8×-8.4×
Price / book23.9×-8.3×23.9×-13.1×26.5×-10.7×28.3×-10.7×32.2×-7.7×
EV / EBITDA93×-25.2×94.1×-38.4×101×-30.5×106.5×-30.1×118.2×-21.4×
Dividend yield1.3%+0.2pp1.4%+0.4pp1.3%+0.4pp1.3%+0.4pp1.1%+0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are West Pharmaceutical Services's profit margins?
West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.
Where do West Pharmaceutical Services's ratios come from?
Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.